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Protocol
AbstrACt
Introduction Non-communicable diseases (NCD) 
now represent the major burden of adverse health in 
most countries. It is clear that much of the risk of such 
conditions begins very early in life, potentially in utero. 
Given their complex aetiology, an understanding of 
the origins of NCD requires an in-depth analysis of the 
interplay between genetic variation and environment, 
preferably over time. For decades, twin studies have 
played a key role in understanding such traits. Their 
strength lies in the ability to disentangle genetic and 
environmental factors that contribute to a phenotype. This 
is done by comparing genetically identical monozygotic 
(MZ) with dizygotic twins, who share on average 50% of 
genetic variation, or by comparing MZ twins within a pair. 
This study aims to determine the relative contributions 
of genes and environment to early-onset intermediate 
phenotypes related to later adult onset disease (such as 
growth and neurodevelopment) and to identify specific 
biomarkers and time points for emergence of phenotypes 
from infancy, largely independent of underlying genetic 
factors.
Methods/design The Chongqing Longitudinal Twin 
Study (LoTiS) will recruit 300 women pregnant with twins, 
enriched for MZ pregnancies, with follow-up to 3 years of 
age. Data collection will be undertaken at key time points 
in gestation (×3), at delivery and postnatally (×9). Maternal 
and infant biospecimens including blood, urine, hair, nails 
and buccal swabs along with measures such as fetal 
scans and body measurements will be collected. Additional 
information from questionnaires and medical records 
includes pregnancy, diet, sociodemographics, maternal 
stress, and infant growth and neurodevelopment.
Ethics and dissemination This study has been approved 
by the Ethics Committee of Chongqing Medical University 
(record no: 201530) and has been registered with the 
Chinese Clinical Trial Registry (registry no: ChiCTR-
OOC-16008203). Results of the recruitment and all 
subsequent analyses will be submitted for publication in 
peer-reviewed journals.
trial registration number ChiCTR-OOC-16008203; 
Results.
bACkground
rising burden of non-communicable diseases
Non-communicable diseases (NCDs), 
comprising mainly cardiovascular disease, 
cancers, diabetes and chronic lung disease, 
caused 36 million deaths in 2008, with 
nearly 80% in low-income and middle-in-
come countries.1 Factors such as increasing 
income, mechanisation, urbanisation and 
improved access to processed food have 
rapidly changed public nutrition and lifestyle 
in developing countries, potentially contrib-
uting to a greater risk of chronic disease.2 
While infectious diseases were the leading 
cause of death in the last century, potentially 
strengths and limitations of this study
 ► The wealth of longitudinal data and biospecimens 
collected as part of this study will enable an 
unparalleled investigation of the factors contributing 
to early-life health and disease.
 ► LoTiS  (Longitudinal twin study) will be the largest 
dedicated longitudinal study yet undertaken of twins 
commencing prior to birth.
 ► The nature of cohort studies means that only limited 
paternal data will be available.
 ► A focus on Chinese participants may limit the 
generalisability of some findings to other populations.
 ► Some biospecimens, such as placenta, will not 
be fractionated to purified cell populations with 
implications for downstream analyses. Others, 
such as stool for microbiome analysis, will not be 
collected.
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preventable NCD, including obesity and cardiovascular 
disease, asthma, allergy and autoimmune disease, cancer 
and mental health problems, will be the major killers in 
the 21st century. For example, the prevalence of self-re-
ported NCD in Guangzhou, China, was 16.0% in 2009, 
higher than the 13.5% in 1999, according to the Regional 
Planning authority (2001–2005). The spectrum of NCD 
also changed during that time, with diabetes rising from 
the sixth most common disease to the second, replacing 
coronary heart disease.3 
Fetal programming and developmental origins of Health and 
disease
Many NCD in adults have their origins in early life. The 
majority are complex with multiple inter-related factors 
operating at many levels over time. Little is understood 
about how and when risk factors translate into chronic 
conditions, but it is clear that the emerging epidemic, 
particularly in developing countries, cannot be explained 
by genetic variation in isolation. Nevertheless, genetic vari-
ation is undoubtedly the foundation on which additional 
environmental-induced risk is established. Mounting 
evidence suggests that environmental cues such as 
maternal nutrition during pregnancy and early postnatal 
life play a key role. Pivotal to this emerging paradigm 
was the observation that individuals born with low birth 
weight were at higher risk of cardiovascular disease.4 This 
idea has evolved into a broader hypothesis spanning many 
exposures and outcomes, the Developmental Origins of 
Health and Disease (DOHaD). DOHaD is supported by 
many direct animal studies and fewer human observa-
tional studies. The paradigm emphasises the likelihood 
that early-life exposures may influence developmental 
pathways and induce long-lasting changes in physiology, 
manifesting as changes in immune, metabolic, neurode-
velopmental and cardiovascular health,5 although the 
underlying mechanisms remain to be fully determined.
Despite this, it is increasingly clear that molecular/
cellular processes act as the mediators of the influence 
of environmental exposures on the underlying genome, 
particularly early in development. However, gaining a 
full understanding of the interaction between exposure 
and genetic variation, molecular mediators and pheno-
typic outcomes is complex, generally necessitating large 
sample sizes studied longitudinally. This is primarily 
to adequately take into account the effects of dynamic 
non-genetic variation and the widespread genetic hetero-
geneity in human populations. The potential of twin 
studies to overcome many of these issues is now widely 
appreciated.
utility of twin studies
Twin studies have played an important role in our 
understanding of individual variation for over a century. 
The comparison between monozygotic (MZ) and dizy-
gotic (DZ) twins allows an estimation of the herita-
bility of traits, which describes the proportion of the 
total variance that is attributable to variance in genetic 
factors within any given population. Further, using 
well-established analytical approaches, the relative 
contributions of genetic, shared and non-shared envi-
ronmental factors to a phenotype of interest can also be 
estimated. A particularly powerful approach to studying 
environmental influence on phenotype lies in the with-
in-pair analysis of MZ twins, discordant for a pheno-
type of interest. Interestingly, despite being genetically 
identical, concordance rates for most complex diseases 
are well below 100%, indicating a role of non-shared 
environmental and/or stochastic factors in modulating 
phenotype.
Longitudinal twin studies now offer the opportunity to 
improve our understanding of the causal pathways under-
pinning a range of early-life phenotypes, particularly 
factors regulating mechanistic processes (eg, epigenetics, 
transcriptomics, metabolomics) thought to influence 
cell function and physiology. The strategic use of iden-
tical twins discordant for complex disease continues to 
reveal the molecular and cellular processes underpinning 
the disease process. Of particular note, we and others 
have demonstrated the importance of non-shared envi-
ronments of twins in utero, particularly the effects of 
maternal and nutrient supply line factors (eg, placental 
structure, umbilical cord insertion point) on neonatal 
epigenetic profile. These effects appear tissue specific and 
locus specific, emphasising that responsiveness to environ-
mental exposures in utero cannot be generalised.6 Such 
complexity in responsiveness to environmental exposures 
in utero has implications for any study investigating the 
developmental origins of health and disease. The longitu-
dinal study of twins, commencing prior to birth, provides 
a unique opportunity in a modest sample size to explore 
the relative role of environmental and genetic factors to a 
range of early complex phenotypes.
To date, there have been few attempts at establishing 
longitudinal twin birth cohorts. Our current study, the 
Peri/Postnatal Epigenetic Twin Study (PETS), was the 
first dedicated longitudinal twin birth cohort study inter-
nationally and was established to allow the investigation of 
factors contributing to epigenetic variation in humans at 
birth and beyond.7 However, although PETS has revealed 
novel insights into DOHaD phenomena, participants 
are almost uniformly of European ancestry and were 
recruited from a population with a ‘Westernised’ lifestyle. 
As such, the generalisability of findings to non-European, 
low/middle-income nations remains unclear. Addition-
ally, PETS did not collect longitudinal maternal samples 
for measurement of environmental pollutants, important 
in any modern cohort aimed to explore DOHaD causal 
pathways. In order to address these issues, we have 
recently established the Chinese Longitudinal Twin Study 
(LoTiS), commencing prior to birth.
AIMs
1. To establish a cohort of 300 Chinese twin pairs and 
their mothers recruited early in pregnancy with 
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longitudinal assessments of exposure and outcome 
measures and biospecimens.
2. To define the relative contribution of genes and en-
vironment (shared and non-shared) to early-onset 
illness or intermediate phenotypes related to adult 
onset disease.
3. To identify specific biomarkers and time points for 
emergence of phenotypes from infancy, largely inde-
pendent of underlying genetic factors.
MEtHods/dEsIgn
LoTiS is a pregnancy cohort based in Chongqing Medical 
University (CQMU), China. The approach for assembly 
of the cohort is based on the successful PETS cohort that 
has been ongoing since 2006.7 As with PETS, women 
pregnant with twins will be recruited. We aim to recruit 
300 women over a 2-year period who are between 11 and 
16 weeks’ gestation (figure 1) and attending the Outpa-
tients Department of Obstetrics, First Affiliated Hospital 
of CQMU, or Department of Obstetrics, Chongqing 
Health Centre for Women and Children. We will follow 
infants through to 3 years of age. All prenatal visits will be 
conducted at the First Affiliated Hospital of CQMU and 
where possible, mothers will deliver at this hospital also. 
Postnatal visits will be conducted either at the Hospital and 
Maternal Child Care Centre, Chongqing, or at CQMU. 
All questionnaires are derived from calibrated scales and 
measures and will be completed in face-to-face interviews 
by trained interviewers. Given the size and duration of 
the initial phase of the study, we will focus on quantitative 
outcomes (continuous variables) often showing discor-
dance within young twin pairs. This includes measures 
of growth and adiposity, body composition, allergic and 
neurodevelopmental outcomes all thought to involve 
environmental modulation of underlying genetic risk. 
Exposure, outcome and molecular data generated during 
this study will be analysed using standard twin modelling 
to partition variance into genetic, shared and non-shared 
environments.
study populAtIon And rECruItMEnt
Mothers pregnant with twins will be recruited from the 
Outpatients Department of Obstetrics at the First Affili-
ated Hospital of CQMU and Department of Obstetrics, 
Chongqing Health Center for Women and Children, 
between November 2015 and December 2017 while 
attending antenatal assessments with an obstetrician 
Figure 1 Flowchart: recruitment to delivery. KAP, knowledge-attitude-practice.
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(figure 1). Women approached in the outpatients depart-
ment by the project manager (PM) will be provided with 
information related to the study. Special emphasis will be 
made in regard to the longitudinal nature of the study 
and the need to provide multiple biospecimens, as well 
as to respond to a series of questionnaires throughout 
the duration of the study. Women will also be informed 
that some biospecimens are optional, requiring a sepa-
rate consent, and that their decision whether to provide 
the optional samples will affect their participation in 
the study. Following an opportunity to ask any questions 
related to the study, women will be given the option to 
consent to participate. Women who meet the inclusion 
criteria for the study and consent to participate will then 
receive an appointment to attend the outpatients depart-
ment for their first study visit.
InClusIon And ExClusIon CrItErIA
Inclusion criteria
 ► Pregnant women attending the Outpatients Depart-
ment of Obstetrics at the First Affiliated Hospital of 
CQMU and Department of Obstetrics at Chongqing 
Health Center for Women and Children.
 ► Gestational age of infants is not more than 16 weeks.
 ► Capacity to provide written, informed consent.
Exclusion criteria
 ► Women with a single pregnancy or multiples higher 
than twins (triplets, etc).
 ► Women more than 16 weeks’ pregnant.
 ► Women with a diagnosis of any of the following in 
pregnancy will be withdrawn from the study by the 
investigators and the reason will be noted:
 – death of one/both infants;
 – twin to twin transfusion syndrome;
 – twin anaemia-polycythaemia sequence;
 – twin reversed arterial perfusion sequence;
 – malformation of one/both infants.
 ► Women who deliver at a birthing centre other than 
the First Affiliated Hospital of CQMU or Chong-
qing Health Center for Women and Children will 
be excluded from the study at this point due to the 
inability for researchers to obtain clinical birth related 
information and samples.
dAtA CollECtIon
Maternal information
Information regarding past and present medical and 
health history, the current pregnancy and sociodemo-
graphic factors (age, education, occupation, families and 
lifestyle factors such as smoking and alcohol consump-
tion history) are collected from pregnant women over 
three prenatal visits to the outpatients department of 
the CQMU or Department of Obstetrics at Chongqing 
Health Center for Women and Children. The first of 
these visits will occur when the women are between the 
11 and 16 weeks’ gestation period, with the second and 
third visits taking place between the 22th–25th and 30th–
34th week of gestation, respectively. A clinical examina-
tion will be conducted at each visit and a range of body 
measurements (weight, height, waist circumference and 
blood pressure) recorded. Biological samples collected 
over this time include blood, urine, hair samples, finger 
nail clippings and buccal (cheek) swabs. Results of liver 
and kidney function tests and fetal ultrasounds will be 
recorded. Questionnaires seeking information about 
maternal stress during pregnancy and dietary habits 
(including supplements) will also be completed.
twins’ information: prenatal
At the 15th–16th week gestation ultrasound scan, twin 
1 and twin 2 will be assigned according to location 
(including placentation site). Measures of estimated 
fetal weight, biparietal diameter, head circumference, 
abdominal circumference and umbilical insertion point 
will also be recorded. Before delivery, an ultrasound will 
be performed to confirm the final intrauterine positions 
of twin 1 and twin 2. Where there is clear evidence of 
opposite sex DZ twins at any ultrasound, these partici-
pants may be excluded from further participation in the 
study as needed. Further, following birth, PCR-STR (short 
tandem satellite repeats) will be performed to identify 
the zygosity in all same-sex twins. The same sex DZ twins 
can then also be excluded as a strategy to enrich the twin 
cohort for MZ twin pairs. During the delivery, before the 
placentas are delivered, the obstetrician on duty marks 
the umbilical cords by clamping a different number of 
haemostatic forceps onto each according to twin number. 
The placentas are then correlated with the newborns 
after determining birth weight.
birth information
At the time of delivery, the PM will attend the birth. 
Detailed information is collected from the medical 
records related to the pregnancy, delivery and any 
medical complications. This includes features of amni-
otic fluid (eg, volume), umbilical cords (length and 
NuA (cord around neck)) and the placenta/s (size and 
weight). The sex of the infants, their birth weight and 
birth length will be recorded along with Apgar scores and 
whether admission to the neonatal unit was required, the 
reason and length of stay. Hair samples from each twin 
will also be collected along with placental tissue samples 
and cord blood (figure 1). Exceptions may occur when 
an emergency delivery with insufficient notice to the PM 
to arrive and/or when the birth occurs during the night. 
Where the PM has been unable to attend the birth at the 
First Affiliated Hospital of CQMU or Chongqing Health 
Center for Women and Children, such as an emergency 
delivery or the birth has occurred during the night, infor-
mation pertaining to the birth will be extracted from 
the clinical records, along with any information about 
the infants (eg, body measurements and Apgar scores) 
within 3 days (before hospital discharge) and samples, 
such as infant hair will be collected. Hospital discharge 
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information will also be recorded which includes infor-
mation about infant feeding.
Should the birth occur at a hospital other than the 
First Affiliated Hospital of CQMU or Chongqing Health 
Center for Women and Children, the family will be 
excluded from the study at this point due to the complete 
lack of clinical birth related information and samples.
twins’ information: postnatal
Mothers and twins will attend the First Affiliated Hospital 
of CQMU or Chongqing Health Center for Women and 
Children for regular visits until they reach 3 years of age 
(figure 2). In order to maximise retention in the study 
postnatally, several incentives will be offered including 
(1) free registration at paediatric clinics, (2) free pheno-
typing such as allergy screening and neurocognitive 
testing, (3) reimbursement of transportation costs and 
(4) access to ‘green channel’ in the hospital, abolishing 
waiting times.
A total of eight postnatal visits are planned, with the 
first commencing 6 weeks following birth (figure 2). 
However, the timing of the first three postnatal visits (all 
Figure 2 Flowchart: postnatal visits. aIMT, abdominal aortic intima-media thickness. 
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of which occur during the first 12 months) are based 
on a predicted gestational age of 40 weeks and adjusted 
accordingly. For example, infants born at 36 weeks’ gesta-
tion will undertake their first postnatal visit 10 weeks 
following their birth, rather than the 6 weeks for a child 
who was born at 40 weeks’ gestation. In addition to ques-
tionnaires about infant feeding and food preferences, 
assessments will be undertaken related to child devel-
opment, temperament, sleep patterns, vision, cardiovas-
cular function, body measurements, body composition, 
allergies, bone density and neurodevelopment. Samples 
collected will include blood and buccal swabs and, where 
possible, maternal urine.
QuEstIonnAIrEs
All questionnaires used are from validated scales and 
measures. The questionnaires have been translated 
into Mandarin by a qualified translator. Information is 
collected from the mother during face-to-face interviews 
by a trained researcher (PM) in Mandarin and trans-
ferred to the database on the same day.
pregnancy stress scale
This validated Pregnancy Stress Scale8 is widely used to 
assess stress levels among Mandarin-speaking pregnant 
women and is a practical tool for use by nurses and 
healthcare workers. The questionnaire will be completed 
by the pregnant women at two time points: 11–16 weeks 
and 30–34 weeks.
There are 36 items in the scale grouped into five 
categories:
1. Stress regarding the pregnancy, labour and delivery 
(nine items). Questions include whether the labour 
will be difficult and whether the baby will be delivered 
safely.
2. Stress from baby care and changing family relation-
ships (nine items). The types of questions asked in 
this section are about concerns around being able to 
breast feed the baby and about caring for the baby.
3. Stress from maternal role identification (eight items) 
ask questions about whether there are concerns about 
how the baby may look, what the baby may weigh and 
about the baby’s sex.
4. Stress from social support seeking (four items). These 
questions are more related to whether there are con-
cerns about access to appropriate support such as 
finding baby-sitters and deciding who will care for 
baby.
5. Stress from altered appearance and function (six 
items). This final section assesses maternal concerns 
about weight gain during pregnancy, and mobility 
due to altered body shape.
gestational nutrition knowledge, attitudes and behaviour
The Gestational nutrition, knowledge, attitudes and 
behaviour questionnaire9 is used to assess knowledge 
about basic nutrition, attitudes and behaviours. There 
are 20 questions in total, 10 of which are used to assess 
nutritional knowledge. Examples include whether they 
think that the more expensive and refined foods are 
more beneficial to health; whether they are aware of 
gestational BMI; which foods are the best sources of iron 
(with choices); best sources of calcium (with choices); 
best sources of vitamin C (with choices) and what kind of 
food deficiency in early pregnancy will increase the occur-
rence of neural tube defects (with choices). Examples of 
the five questions assessing attitudes to nutrition include 
whether the women will be looking for information about 
nutrition during pregnancy; whether their diets should 
be based on meals and supplemented by supplements 
and whether eating foods they dislike, but good for 
baby, will be a problem. The final section of this ques-
tionnaire asks about behaviours in relation to nutrition. 
There are five questions and these ask about nutritional 
supplements taken during pregnancy, and which of the 
food groups were eaten daily (with choices) and about 
the type and duration of exercise during the pregnancy. 
This information will be collected between the 11 and 16 
weeks’  gestation.
brief Infant sleep Questionnaire
Infant sleep patterns are assessed using the Brief Infant 
Sleep Questionnaire,10 which is a reliable assessment tool 
for assessing and screening for infant sleep problems. 
The twins are assessed at 6 months of age and informa-
tion collected include such sleep measures as nocturnal 
sleep duration, daytime sleep duration, the number of 
times the infant wakes during the night, the duration of 
wakefulness during the night, nocturnal sleep onset time, 
location of sleep and preferred body position.
bayley III scales of Infant development—Chinese revision
The Bayley Scales of Infant Development—Chinese Revi-
sion11 is a standardised assessment of motor (fine and 
gross), language (receptive and expressive) and cognitive 
development of infants, toddlers and preschool children 
(ages 2–30 months). It is administered by a trained profes-
sional and consists of a series of a range of play tasks. This 
assessment is undertaken at 18 months of age.
Carey toddler temperament Questionnaire
The Carey Toddler Temperament Questionnaire12 is 
used to determine the sensitivity of the child to external 
stimulus and the intensity of their response. A range 
of questions are asked about emotional reactions to 
food, animals, strangers, concentration levels, ability to 
socialise and interact with others, mood swings, ability to 
cooperate with others and share toys. This assessment is 
conducted at 30 months of age.
Food Frequency Questionnaire (FFQ)
FFQ is used to assess the dietary intake, nutritional status 
and dietary patterns in relation to pregnancy outcomes. 
Information about the frequency and amount of food 
items consumed in the previous 3 months is recorded in 
face-to-face interviews by a trained researcher at two time 
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points: 11–16 weeks’ and 30–34 weeks’ gestation. Nine-
ty-five questions relate to the consumption of breads, 
cereals, noodle meals, vegetables, bean curd, fruits, 
poultry, meat dishes, biscuits, pastries, cakes, snacks, 
milk and dairy foods. Fifteen questions relate to dietary 
behaviours.
twenty-four-hour food recall questionnaire
The 24-hour food recall questionnaire13 14 is used to 
record detailed food intake within the 24-hour period up 
to the most recent meal. This questionnaire is designed 
to identify dietary patterns and related behaviours. A 
trained researcher, equipped with standardised utensils 
and pictures to guide the women in relation to portion 
sizes, conducts the questionnaire in a face-to-face inter-
view. The women are asked to recall information about 
their consumption of food. Questions relate to the name 
and amount of the different foods consumed, and also 
the place where each was consumed. This assessment is 
conducted along with FFQ.
nutrition Questionnaire for Children
The Nutrition Questionnaire for Children15 consists of 
three parts. The first is feeding survey with a total of 25 
questions. Examples include the following: What is the 
feeding pattern of your child in the first 6 months? What is 
the time of the introduction of solids? Is food specifically 
prepared for your child? How many times does your child 
feed each day? The second part is a 24-hour food recall 
questionnaire, and the third part is a Food Frequency 
Questionnaire which has been specifically designed for 
LoTiS infants. This assessment is to be conducted sepa-
rately for all twins at 12 months of age.
Medication use
We are collecting all information of medication use 
around the time of pregnancy along with a history of 
diseases at the time of recruitment. Medication prescrip-
tion during pregnancy is also being recorded.
sAMplEs
Maternal blood
Peripheral blood will be collected at each of the three 
prenatal visits by venepuncture for assessment of 
maternal complex lipids, micronutrients and endocrine 
status, collection of live lymphocytes and for DNA/RNA 
extraction. A total of 15 mL of blood will be collected at 
each visit: 6 mL in a 10 mL coagulant tube (for serum) 
and 6 mL in a 10 mL EDTA anticoagulant tube (plasma, 
leucocytes and red cells), with the remaining 3 mL in a 
5 mL heparin anticoagulant tube (for plasma). Samples 
will be transported to the laboratory within 2 hours of 
collection for processing and storage as serum, plasma, 
red cells and leucocytes.
Cord blood and placental tissues
Umbilical cord blood will be collected from the umbil-
ical vein into a 10 mL EDTA anticoagulant tube, a 5 mL 
heparin anticoagulant tube and a 10 mL procoagulant 
tube. A 4 mm skin biopsy punch will be used to randomly 
sample 20 pieces (2 mm×2 mm×4 mm per piece) of 
placenta tissue from each of the fetal and maternal 
surfaces. The samples will be immediately placed in a 
precooled (4°C) physiological saline solution for trans-
portation to the laboratory for cold storage at −80°C 
within 30 min of collection.
oral glucose tolerance test
An oral glucose tolerance test will be undertaken at the 
second prenatal visit when the women are between 22 
and 25 weeks’ pregnant to test for gestational diabetes. 
Measures recorded are fasting glucose levels, 60 min post-
prandial blood glucose level and 120 min postprandial 
blood glucose level.
urine samples
A midstream urine sample is to be collected at each 
maternal prenatal visit to provide information about envi-
ronmental exposures (such as bisphenol A). Cleaning 
wipes will be used to clean vulva before collection. A 
15 mL sterile centrifuge tube will be used to collect 10 mL 
of urine. Following transportation to the laboratory, the 
samples will be centrifuged at 3000 rpm for 10 min and 
then aliquoted into 250 µL QR code tubes, and stored in 
−80°C within 30 min of processing.
Hair
Maternal hair will be collected for metabolomic and toxin 
measures at the first prenatal visit to assess both acute and 
chronic exposure to a range of minerals and toxins. The 
sample comprise approximately 30 hairs cut close to the 
scalp. Following the twins’ births, approximately three 
tufts of infant hair will also be cut close to the scalp and 
stored for future analysis. Foil paper will be used to wrap 
around hairs at the time of collection with labelling to 
identify the scalp proximal end. The samples will be trans-
ported in cold storage to the laboratory within 2 hours of 
collection with long-term storage at −20°C.
nails
Maternal fingernail samples are to be collected in the 
first and third prenatal visit for measure of chronic envi-
ronmental exposures (such as heavy metals). Following 
collection, nails will be immediately wrapped in foil and 
then transported to the laboratory within 2 hours of 
collection for immediate storage at −20°C.
buccal swabs
Buccal swabs will be used to collect cheek cells at all three 
maternal prenatal visits. DNA will be extracted from the 
swabs for later genetic and/or epigenetic testing. At the 
age of 6 weeks, cheek cells will be collected in the same 
manner from each twin. Prior to collection, participants 
will be asked to refrain from consuming food and liquids 
for 30 min. To collect the cells, a sterile oral swab will 
be used to rub the oral mucosa of each cheek about 10 
times. The swabs will then be immediately stored in sterile 
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tubes, and conserved in a −80°C freezer. The DNA will be 
extracted from the swabs within a month of sample collec-
tion and again stored at −80°C.
AssEssMEnts
body measurements
Maternal body measurements will be performed at all 
three prenatal visits to assess weight gain and fetal develop-
ment during pregnancy. For the first visit, height, weight 
and blood pressure will be recorded. For subsequent 
visits, weight, blood pressure, fundal height, abdominal 
circumference and fetal heart rate will be recorded. 
Infant body measurements are to be taken at birth and 
repeated at each of the eight follow-up visits by trained 
paediatric nurses to assess growth and development. A 
stadiometer (Beideneng, Shanghai, China) will be used 
to assess maternal height and weight, and corresponding 
infant information will be recorded on a growth curve. A 
standard measuring tape will be used to determine head 
circumference, chest circumference, abdominal circum-
ference, and a digital body fat calliper will be used to 
determine skin fold thickness.
body composition
Information about the twins’ body composition will be 
collected at birth, and infant ages 6 weeks, 6 months, and 
1, 2 and 3 years. This information will be used in conjunc-
tion with body measurements to gain insights into body 
composition. Parameters of total body water, fat mass, fat 
free mass, extracellular fluid, intracellular fluid and body 
mass index are collected by body composition analyser 
(Imp SFB7, Australia).
delivery record
Information from the delivery record will be collected. 
This will include details about the method of delivery 
(caesarean or vaginal) and any preoperative and postop-
erative diagnosis that was made along with the size and 
weight of the placenta/s, the length of the umbilical 
cords, amniotic fluid volume and character. The infants’ 
gestational age at delivery, their sex, weight, length and 
Apgar scores will also be recorded.
respiratory function
Respiratory function will be measured by a trained profes-
sional when the infants are 2 years of age using tidal 
breathing analysis. A pulmonary function test apparatus 
(CareFusion, Germany) will be used to determine lung 
function parameters of respiratory rate, tidal volume, 
inspiratory time, expiratory time, time to reach peak tidal 
expiratory flow, expired volume at peak tidal expiratory 
flow, the ratio of inspiratory time to expiratory time and 
the ratio of time to reach peak tidal expiratory flow to 
total expiratory volume.
Cardiovascular function
When the twins are 6 weeks of age, an experienced sonog-
rapher will measure their cardiovascular function via 
transabdominal ultrasound. Both aortic intima media 
thickness and aortic diameter will be obtained using a 
commercially available system (Voluson E8, GE Health-
care, Austria) which is equipped with a C4-8 transducer 
(frequency 4–8 MHz).
liver and kidney functions
Maternal liver and kidney functions are assessed during 
early (11–16 weeks) and late (30–34 weeks) pregnancy. 
Serum is collected from the women following an 8-hour 
period of fasting. The sera are examined at the clinical 
laboratories of the First Affiliated Hospital of CQMU 
or Chongqing Health Center for Women and Children. 
Measures will include total protein, albumin, globulin, 
total bile acid, aspartate aminotransferase, alanine amino-
transferase, urea and creatinine.
ultrasound scans
Fetal ultrasound scans will be obtained at each prenatal 
visit according to standard guidelines. A trained medical 
sonographer using a commercially available system 
(Voluson E8, GE Healthcare) equipped with a transducer 
(frequency 5–10 MHz) will conduct this assessment. 
Measures taken will include estimated fetal weight, bipa-
rietal diameter, head circumference, abdominal circum-
ference and umbilical insertion point. Before delivery, a 
bedside ultrasound will be performed to confirm the final 
intrauterine position of twin 1 and twin 2.
sAMplE storAgE And bIobAnk
All samples except hair and nails will be saved in QR code 
preprinted 500 µL cyrovials (Micronic, The Netherlands). 
The hair and nail samples will be wrapped in foil at point 
of collection, and saved in resealable bar-coded bags. 
Prior to storage in a biobank facility, each sample will be 
scanned by a Tracxer code reader (Micronics) enabling 
the sample and its location to be tracked in the database 
(Medscinet AB, Sweden).
Hair and nail samples will be stored in −20°C freezers 
(Zhongke MeiLing, China). Placental tissues will be 
preserved in liquid nitrogen tanks (Locator 4 Plus). All 
other samples (urine, serum, DNA) will be stored in −80°C 
freezers (907, Thermo Fisher Scientific, American).
The −80°C freezers (907, Thermo Fisher Scientific, 
American) have temperature sensors (PT100) and a 
monitoring system (Smart-Vue, Thermo Fisher Scientific, 
France) as well as a backup liquid nitrogen cooling system 
(DPL452, Taylor Wharton, USA).
dAtAbAsE
The database used to store all information was designed 
and implemented by Medscinet AB. This company has 
been used to build similar data collection and storage 
bases for other population-based studies. Data will be 
stored in both Mandarin and English languages for 
extraction or annotation in either language.
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dAtA AnAlysIs
The extensive longitudinal data and sampling of biospe-
cimens planned in Chongqing LoTiS affords consider-
able scope for addressing a range of research questions, 
from observational mapping of growth trajectories 
through epidemiological investigation of a range of 
maternal factors (between pairs), or non-shared envi-
ronmental factors (within pairs) on offspring outcome. 
A key part of future studies will be the generation of a 
range of ‘-omics’ type data, particularly genomics, epig-
enomics, transcriptomics and metabolomics. Genera-
tion and analysis of this will initially be carried out using 
standard approaches applicable to each type of data to 
yield a ‘clean’ dataset for each individual. Subsequent 
standard twin modelling approaches can then be used 
to partition the variation of specific phenotypic traits or 
‘-omics’ outputs into constituent variance components 
of additive genetic, non-additive genetic, shared envi-
ronmental (eg, maternal factors) and non-shared envi-
ronmental influences (eg, placental features). Between 
pair comparisons of similarity measures (eg, intraclass 
correlation coefficient) are a simple way to assess the 
likelihood of a genetic influence on any specific pheno-
type. Additional logistic regression approaches, incor-
porating twin relatedness into each model, will also be 
employed as required.
EtHICs And dIssEMInAtIon
Data from the study will be published in medical 
research journals, and any molecular data will be 
published in appropriate public repositories.
dIsCussIon
Numerous studies have revealed that genetically iden-
tical mice reared in the same environmental condi-
tions show normally distributed variation in most 
phenotypes, most likely driven in part by non-genetic 
processes.16 Longitudinal measurement of such mech-
anisms in twins can provide a unique opportunity to 
identify genes sensitive to the environmental factors 
that are associated with complex disease.
LoTiS is specifically designed to combine the power 
of twin study design with longitudinal sampling of expo-
sure, biospecimens and phenotypic outcomes predictive 
of later NCD, commencing prior to birth. Being based 
in China offers considerable importance both in terms 
of providing a non-European-based genetic profile, 
but also to address the unique nature of exposure/
outcomes inherent to developing economies under-
going rapid Westernisation in terms of exposures and 
incidence of a range of NCD.
Whereas a comparison between DZ and MZ twins will 
reveal the relative contribution of genetic and environ-
mental variation to early-life phenotypes, the capacity 
to control for genetic variation using within MZ twin 
pair comparisons will prove particularly valuable in 
helping to unravel the complexity of gene–environ-
ment–epigenetic interactions and their contribution to 
human health and disease.
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